Dr. Gangat is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St SW
Rochester, MN 55905Phone+1 507-284-2511
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2007 - 2010- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2004 - 2007
Aga Khan Medical CollegeClass of 2002
Certifications & Licensure
MN State Medical License 2006 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Clinical Trials
- Actuate 1901: 9-ING-41 in Myelofibrosis Start of enrollment: 2020 Aug 20
Roles: Contact
Publications & Presentations
PubMed
- High-dose IV ascorbic acid therapy for patients with CCUS with TET2 mutations.Zhuoer Xie, Jenna Fernandez, Terra Lasho, Christy Finke, Michelle Amundson
Blood. 2024-12-05 - 1 citationsPHF6 mutations in chronic myelomonocytic leukemia identify a unique subset of patients with distinct phenotype and superior prognosis.Ayalew Tefferi, Saubia Fathima, Ali Khalid A Alsugair, Fnu Aperna, Anuya Natu
American Journal of Hematology. 2024-12-01 - Incidental changes in hemoglobin levels in patients with myelofibrosis receiving treatment with sodium-glucose co-transporter-2 inhibitors.Fnu Aperna, Ali K Alsugair, Saubia Fathima, Ayalew Tefferi, Naseema Gangat
Haematologica. 2024-11-28
Journal Articles
- MPL-Mutated Essential Thrombocythemia: A Morphologic ReappraisalNaseema Gangat, Natasha Szuber, Rhett P Ketterling, Nature
- Determinants of Long-Term Outcome in Type 1 Calreticulin-Mutated MyelofibrosisNaseema Gangat, Natasha Szuber, Rhett P Ketterling, Nature
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
